Melatonin for Sleep: When It May Help and Key Precautions

Melatonin has become one of the best-known options for people hoping to fall asleep faster or improve their sleep. However, describing it simply as a “natural sleeping pill” misses an important part of how it works.

Melatonin is primarily a hormone involved in coordinating the body’s internal clock. That helps explain why the evidence is stronger for certain circadian rhythm problems than for treating every form of sleeplessness. (NCCIH)

Understanding that distinction can prevent unrealistic expectations and prolonged supplement use when the underlying sleep problem may require a different approach.

What is melatonin?

The brain naturally produces melatonin in response to darkness. Its release contributes to the timing of circadian rhythms — roughly 24-hour biological cycles that influence sleep and wakefulness. Light exposure at night can suppress its production. (NCCIH)

Melatonin therefore acts partly as a biological timing signal. It should not be understood simply as a chemical switch that immediately causes sleep.

This distinction becomes particularly relevant when sleep problems are caused by a mismatch between someone’s internal clock and the time they need to sleep.

When can melatonin help?

Jet lag

Jet lag occurs when rapid travel across time zones leaves the internal body clock temporarily aligned with the time at the point of departure.

Research reviewed by NCCIH suggests that melatonin can reduce some symptoms of jet lag. Although the size of the benefit varies between studies, jet lag remains one of the better-supported uses of supplemental melatonin. (NCCIH)

Timing is especially important in this situation because the goal is not merely to produce drowsiness but to help shift the circadian system toward the new time zone.

Delayed sleep-wake phase disorder

Some people can sleep normally when allowed to follow a very late schedule but find it extremely difficult to fall asleep or wake up at conventional times.

This pattern can occur in delayed sleep-wake phase disorder. Evidence reviewed by NCCIH indicates that appropriately timed melatonin may help some people with this condition, although recommendations remain cautious and timing is a key part of treatment. (NCCIH)

That is one reason taking melatonin at an arbitrary time may not produce the desired circadian effect.

What about ordinary insomnia?

The evidence becomes less convincing when the target is chronic insomnia.

Insomnia can involve difficulty falling asleep, staying asleep, or returning to sleep. Its causes and maintaining factors can vary substantially from one person to another.

The American Academy of Sleep Medicine’s 2017 pharmacologic guideline suggested that clinicians not use melatonin for sleep-onset or sleep-maintenance insomnia in adults. The recommendation was classified as weak, reflecting limitations in the evidence rather than proof that melatonin can never help an individual. (PubMed)

A 2022 systematic review and meta-analysis likewise found no statistically significant improvement in several major sleep outcomes among adults with chronic insomnia. (PubMed)

In practical terms, some individuals may report benefit, but the overall research does not support treating melatonin as a dependable solution for every case of chronic insomnia.

Addressing chronic insomnia requires more than a supplement

When sleep difficulties persist, adding a supplement without addressing the factors maintaining insomnia may not solve the underlying problem.

The American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for adults with chronic insomnia. CBT-I addresses sleep-related behaviors and thought patterns and is more comprehensive than generic “sleep hygiene” advice alone. (PubMed)

This also explains why repeated melatonin use may accomplish little for some people: chronic insomnia is not necessarily a disorder of insufficient melatonin production.

Is there an ideal melatonin dose?

There is no single universal dose that can responsibly be recommended for every person and every sleep problem.

A 2024 systematic review and dose-response meta-analysis found that sleep outcomes varied according to factors including dose and timing of administration. The findings reinforce why copying a dose from social media, a friend, or a product marketed in another country is not equivalent to individualized medical guidance. (PubMed)

Higher doses should also not automatically be assumed to work better. Particularly in circadian applications, timing can be central to the intended effect.

Regulations vary substantially between countries

Melatonin is not regulated in the same way everywhere.

In the United States, NCCIH notes that melatonin is sold as a dietary supplement and is regulated differently from prescription and over-the-counter drugs. In several other countries, it is treated as a medicine requiring a prescription. (NCCIH)

Brazil provides another example. Melatonin is authorized there as a dietary supplement for adults, with a maximum of 0.21 mg in the recommended daily intake, and dietary supplements cannot make therapeutic claims that they treat insomnia or improve sleep. (Serviços e Informações do Brasil)

Because of these differences, doses and product claims encountered online cannot automatically be transferred from one country to another.

What side effects can melatonin cause?

Melatonin has generally been relatively well tolerated in short-term studies, but it can still cause adverse effects.

A systematic review identified daytime sleepiness, headache, and dizziness among the more frequently reported adverse events. Institutional sources also describe symptoms such as nausea and other sleep-related effects. (PubMed)

Daytime drowsiness is particularly relevant for driving, operating machinery, or performing other activities that require sustained attention.

Can melatonin interact with medications?

Yes. Supplement status does not eliminate the potential for clinically important interactions.

NCCIH specifically advises medical supervision for people with epilepsy and those taking blood-thinning medications. Brazilian health authorities likewise advise people with medical conditions or those using medication to consult a healthcare professional before consuming melatonin supplements. (NCCIH)

This is one reason a complete medication and supplement history matters when melatonin is being considered.

What about children, pregnancy, and breastfeeding?

These groups require additional caution.

In Brazil, melatonin dietary supplements are not authorized for children, pregnant people, or those who are breastfeeding. NCCIH also emphasizes substantial uncertainty about pediatric use, including questions about appropriate dosing, timing, and long-term effects. (Serviços e Informações do Brasil)

Melatonin is used medically for selected pediatric sleep problems in some settings, but evidence from specialist-managed situations should not be interpreted as support for unsupervised supplementation.

Is long-term melatonin use safe?

This remains an important unanswered question.

NCCIH states that short-term supplementation appears relatively safe for most people studied, while information about long-term safety remains insufficient. (NCCIH)

In November 2025, preliminary research presented at the American Heart Association’s Scientific Sessions reported an association between recorded long-term melatonin use among people with insomnia and higher rates of heart failure, heart-failure hospitalization, and all-cause mortality. (American Heart Association)

These findings do not show that melatonin causes heart failure. The analysis was observational and preliminary, so differences between long-term users and nonusers — including underlying illness, insomnia severity, medication use, and how melatonin exposure was recorded — may have affected the results. (American Heart Association)

The study therefore should not be used to create alarm or to encourage people to abruptly stop professionally supervised treatment. It does, however, reinforce why years of nightly supplementation should not automatically be assumed harmless without adequate evidence.

Supplement quality matters too

The amount in a supplement may not always perfectly match what appears on its label.

NCCIH cites analyses of commercially available melatonin products in which the actual melatonin content differed substantially from the labeled amount. Some products in one analysis also contained undeclared serotonin. (NCCIH)

These findings do not mean every melatonin product is inaccurate, but they demonstrate why manufacturing quality and appropriate regulation matter.

Start by identifying the sleep problem

Instead of asking only whether melatonin “works,” a more useful question is what type of sleep problem is being treated?

Sleep disruption after crossing several time zones is biologically different from insomnia that has persisted for months. Likewise, a person whose natural sleep period occurs much later than their required schedule may have a different problem from someone who remains awake despite an appropriately timed sleep opportunity.

Those distinctions help explain why the same supplement may benefit one person and do little for another. Current evidence supports targeting the actual sleep pattern rather than treating all sleep difficulties as interchangeable. (NCCIH)

When should you seek professional advice?

Persistent sleep problems, significant daytime impairment, or repeated reliance on sleep supplements are reasonable reasons to seek professional assessment.

Professional guidance is particularly important when medical conditions or regular medications are involved, during pregnancy or breastfeeding, or when melatonin is being considered for a child. (NCCIH)

The goal is not to medicalize every occasional poor night’s sleep. It is to avoid masking an ongoing sleep problem with self-treatment while its underlying cause remains unaddressed.

Conclusion

Melatonin can be useful, but its usefulness depends greatly on why someone is having trouble sleeping.

Evidence is more favorable for certain circadian problems, including jet lag and delayed sleep-wake timing. For chronic insomnia in adults, findings are less consistent, and cognitive behavioral therapy for insomnia has an important first-line role. (NCCIH)

Potential side effects, medication interactions, product quality, regulatory differences, and uncertainties about prolonged use also matter. Preliminary cardiovascular findings reported in 2025 add another question for future research, but they do not establish that melatonin itself causes cardiovascular disease. (American Heart Association)

Rather than viewing melatonin as an automatic solution for “better sleep,” the safer approach is to identify the sleep problem, the intended goal, and whether melatonin is actually appropriate for that situation.

This content is for educational and informational purposes and does not replace diagnosis, treatment, or individualized advice from a qualified healthcare professional.